Contrary to our expectation, the expression of RAD51 or p21, which are the known targets of CHD4 as it was shown in other cancer types [40,53,54], was not clearly affected by CHD4 knockdown in the ovarian cancer cells we tested. The gene discussed is CHD4; the disease is ovarian carcinoma.